Tarsus Pharmaceuticals TARS
NASDAQ TARS
$73.00 -2.46 (-3.26%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Selling, General & Administrative (2019 - 2026)

Updated

Tarsus Pharmaceuticals (TARS) reported Selling, General & Administrative of $150.7 million for Q2 2026, up 46.3% from $103.01 million a year earlier and up 10.5% from the prior quarter.

Analysis

Tarsus Pharmaceuticals (TARS) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Tarsus Pharmaceuticals' Selling, General & Administrative came in at $526.44 million, up 67.2% year-over-year; for FY2025, it was $427.32 million, up 80.1% from FY2024.

  • Selling, General & Administrative has increased for six consecutive years, with a five-year compound annual growth rate of 120.6% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $237.31 million in FY2024 (+118.3%), $108.7 million in FY2023 (+141.8%), $44.95 million in FY2022 (+77.0%) and $25.4 million in FY2021 (+210.8%).
  • The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q3 2019.
  • Year over year, Selling, General & Administrative has now increased in each of the last 24 quarters, with growth averaging 71.9% over the last eight quarters.
  • Across the past five years, year-over-year growth in Selling, General & Administrative ran from 46.3% in Q2 2026 to 241.7% in Q1 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $136.43 million (Q1 2026), $130.68 million (Q4 2025) and $108.63 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Tarsus Pharmaceuticals 3.16 Bn 2.10 Bn 161.80 Mn 150.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150.70 Mn
Mar 31, 2026 136.43 Mn
Dec 31, 2025 130.68 Mn
Sep 30, 2025 108.63 Mn
Jun 30, 2025 103.01 Mn
Mar 31, 2025 85.00 Mn
Dec 31, 2024 69.03 Mn
Sep 30, 2024 57.91 Mn
Jun 30, 2024 58.79 Mn
Mar 31, 2024 51.58 Mn
Dec 31, 2023 43.01 Mn
Sep 30, 2023 30.32 Mn
Jun 30, 2023 20.28 Mn
Mar 31, 2023 15.10 Mn
Dec 31, 2022 14.63 Mn
Sep 30, 2022 11.99 Mn
Jun 30, 2022 10.38 Mn
Mar 31, 2022 7.95 Mn
Dec 31, 2021 6.77 Mn
Sep 30, 2021 6.67 Mn
API Access

Tarsus Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TARS&period=max&api_key=YOUR_API_KEY